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INTRODUCTION
Stroke, a focal neurological deficit of sudden onset, is a 
heterogeneous condition made up of three pathological 
types: cerebral infarction, cerebral hemorrhage and 
subarachnoid hemorrhage. Cerebral infarction is then 
further divided into various subtypes, such as intracranial 
small vessel disease, large-vessel atherosclerotic disease, 
1and embolism from the heart.
Stroke is the second leading cause of death worldwide, 
and the leading cause of acquired disability in adults in 
most regions. Fifteen million people worldwide suffer a 
stroke each year with devastating effects; one third of 
these individuals die and another one third remains 
permanently disabled. However, there is a considerable 
 additional unreported asymptomatic cerebrovascular 
disease. According to the literature, MRI-defined silent 
brain infarcts can be detected in 20% of healthy elderly 
1-3people and up to up to 50% of patients in selected series.   
The burden of stroke is globally increasing and in 
 countries such as the United States of America, there are 
about 795,000 new and recurrent strokes per year 
compared with 1,350,000 new and recurrent coronary 
events.  In the west, about 85% of strokes are due to 
 ischemic stroke, and about 15% are due to hemorrhagic 
stroke, however studies in Africa found higher incidence 
1,3-5of intracerebral hemorrhages at 35%.
Strokes cluster in families and family history of stroke is 
regarded by both clinicians and the lay public as one of 
important risk factor for the development of 
cerebrovascular disease. Nevertheless, data on the 
6genetic epidemiology of stroke remains conflicting.  
The purpose of this article is to review studies on familial 
aggregation of strokes. 
For better analysis of literature, we report 
separately ischemic and hemorrhagic strokes, and 
subarachnoid hemorrage.  
 
  
We searched for studies of family 
history of stroke and twin studies using bibliographic 
databases and by hand-searching reference lists and 
journals. 
Ischemic stroke
Ischemic stroke is a complex disorder caused by a 
combination of genetic and environmental factors. It 
clusters in families and can be the presenting feature of a 
number of single-gene disorders, but much more common 
is the sporadic multifactorial form of this disease. Clinical 
and epidemiological studies have provided evidence for 
6,7 genetic influences in the development of stroke. A 
number of mendelian traits featuring stroke have been 
described. The late onset of the non-mendelian, common 
ischemic stroke and the mode of inheritance, which is 
complex, polygenic and multifactorial makes it difficult 
to follow up families with this disorder. In addition, 
ischaemic stroke consists of a number of different 
phenotypes which might each have different genetic 
7,8profiles and run in families.  We will discuss separately 
familial aggregation in single-gene disorder associated 
with ischemic stroke and then in the polygenic, more 
frequent, multifactorial ischemic stroke.  
Familial aggregation in monogenic disorders 
associated with Ischemic stroke
 Many rare mendelian traits occurring from a 
single-gene defect have been illustrated in which stroke is 
 a recognized component. Several monogenic disorders 
can cause large-artery and small-vessel stroke. Generally 
these represent a small percentage of strokes and will be 
mostly considered if stroke occurs in young patients with 
little or no exposure to conventional vascular risk 
9,10factors.  The mechanisms by which these disorders 
result in stroke are diverse and include large arterial 
disease, small vessel disease, cardioembolism, 
mitochondrial disorders and connective tissue disorders 
leading to arterial dissection. However, some familial 
conditions predispose to stroke by more than one 
mechanism. We will discuss separately familial 
Familial aggregation, the increased risk of disease among 
family members compared to the general population, can 
be attributable to both shared environmental and genetic 
exposures.
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aggregation in large artery, small vessel and 
cardioembolic diseases.
Large artery disease 
These patients will have clinical and brain imaging 
findings of either significant (>50%) stenosis or 
occlusion of a major brain artery or branch cortical artery, 
presumably due to atherosclerosis. Clinical findings 
include those of cerebral cortical impairment (aphasia, 
neglect, restricted motor involvement, etc.) or brain stem 
or cerebellar dysfunction. Cortical or cerebellar lesions 
and brain stem or subcortical hemispheric infarcts greater 
than 1.5 cm in diameter on CT or MRI are considered to be 
1,11 of potential large-artery atherosclerotic origin. This 
stroke can run in families with single-gene disorders 
including homocysteinuria, dyslipidaemias and sickle 
cell disease. 
Homocysteinuria is an inherited disorder that affects the 
metabolism of methionine. It is inherited in families as an 
autosomal recessive trait and causes stroke by 
thromboembolic vascular events. Several autosomal 
dominant and recessive enzyme deficiencies exist which 
can lead to a high level of homocysteine in both plasma 
and urine, and this condition is referred to as 
homocysteinuria. Homocysteine is believed to be toxic to 
endothelial cells and to predispose to a prothrombotic 
12state, and it is associated with premature atherosclerosis.  
According to one study, one-half of the patients with 
inherited cystathione â-synthase deficiency suffered from 
a thromboembolic episode before the age of 29 years, and 
13in 32% of these cases this was a cerebrovascular event.  
Treatments to lower plasma homocysteine levels and 
stroke risk include pyridoxine, methionine-restricted diet, 
folate and vitamin B12 supplementation, and betaine.
Several studies have suggested that mild to moderate 
elevations of serum homocysteine are associated with 
increased risk of vascular disease. Homocysteine levels 
tend to be higher in individuals homozygous for the 
thermolabile variant of the methylene tetrahydrofolate 
reductase (MTHFR) gene, due to a C-to-T transition at 
position 677. Studies found an increased risk of 
atherothrombotic stroke in carriers of the TT genotype of 
14,15the 677C_T variant in MTHFR.  
Hereditary dyslipidaemias linked with premature 
atherosclerosis may lead to early stroke. Elevations of 
LDL cholesterol can result from single gene defects or be 
associated with polygenic disorders or secondary to other 
diseases. Familial hypercholesterolemia is due to 
mutations in the gene for the LDL receptor. Familial 
 
Defective Apo B100, an autosomal dominant disorder, is 
due to a missense mutation at aminoacid 3500 that 
reduces the affinity of LDL for the LDL receptor thus 
16impairs LDL catabolism.  The association between these 
disorders and ischemic stroke is less well described than 
that with coronary artery disease, but a relation has been 
reported in several disorders, including familial 
h y p o a l p h a l i p o p r o t e i n a e m i a ,  f a m i l i a l  
hypercholesterolaemia (homozygous form), type II and 
17type IV hyperlipidemia and Tangier's disease.  
Sickle cell disease may cause cerebral infarction via both 
arterial involvement and a prothrombotic predisposition. 
Stroke, an important complication of sickle cell disease, 
affects around 8% of children with homozygous sickle 
cell disease in the first 14 years of life and up to 25% in 
patients aged 45 years and above including both large-
artery and small-vessel ischemic stroke and hemorrhagic 
18stroke.  Large-artery strokes are due to intimal 
thickening, fibroblast and smooth muscle cell 
proliferation, and thrombus formation, mainly in the 
distal internal carotid artery and the proximal middle and 
anterior cerebral arteries. Small-vessel strokes are 
probably caused by sludging and intravascular sickling in 
smaller vessels. Transfusion therapy can reduce the risk of 
19,20stroke.
A prothrombotic state resulting from a deficiency of 
protein C and protein S is a well documented cause of 
familial venous thrombosis. The association with arterial 
stroke is less strong. Reduced levels of proteins C and S 
may occur transiently after stroke, while low levels may 
be seen in patients on warfarin therapy and in conditions 
such as liver disease, disseminated intravascular 
21coagulation and renal disease. But in the presence of a 
family history of premature thrombosis, the association is 
likely to be causal. In elderly individuals, the relationship 
between the levels of these natural anticoagulants and 
stroke appears to be weak. Furthermore, the risk of venous 
thrombosis is much higher than that of arterial thrombosis 
hence the likelihood of a patent foramen ovale leading to a 
right-to-left cardiac shunt should therefore be considered 
in patients with stroke (paradoxical embolism). 
Antithrombin III deficiency, inherited as an autosomal 
dominant trait, is also largely associated with venous 
thrombosis but uncommon cases of arterial stroke have 
21,22,23been reported.  
Small vessel disease
In this category we include patients whose strokes are 
often labelled as lacunar infarcts. The patient should have 
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should not have evidence of cerebral cortical dysfunction. 
A history of diabetes mellitus or hypertension supports 
the clinical diagnosis. The patient should also have a 
normal CT/MRI examination or a relevant brain stem or 
subcortical hemispheric lesion with a diameter of less 
than 1.5 cm demonstrated. Small vessel disease is a 
pathological term used to refer to the structural changes 
affecting the small penetrating end arterioles which 
11supply the deep white matter and basal ganglia.  Lacunar 
strokes can run in families with single gene defect such as 
CADASIL or Fabry's disease.
CADASIL, Cerebral Autosomal Dominant Arteriopathy, 
Subcortical Infarcts and Leukoencephalopathy, is a rare 
autosomal dominant disease caused by mutations in the 
Notch3 gene on chromosome 19. The clinical phenotype 
is characterized by 
subcortical stroke-like episodes, which occur commonly 
in mid-adulthood in the absence of usual vascular risk 
24factors. The underlying vascular lesion is a non 
arteriosclerotic, amyloid-negative angiopathy involving 
small arteries and capillaries. Since these changes have 
been reported in the small vessels supplying the 
peripheral nerves, skin, muscle, and occasionally the 
viscera, indicating the presence of systemic arteriopathy, 
skin biopsy has been used in the diagnosis. MRI reveals 
leucoencephalopathy and small deep infarcts 
(leucoariosis) in all symptomatic patients, both focal 
lacunar infarcts and diffuse leucoariosis are seen on T -2
weighted images. In patients with a characteristic 
phenotype and family history, the approach to screening 
is to initially look for mutations in exons 3 and 4, and also 
to consider a skin biopsy. Though it is diagnostic if 
granular osmiophilic material is present, the skin biopsy 
24,25 can be normal.
Fabry's disease is an X-linked recessive disorder due to 
á-galactosidase A deficiency, stroke occurs most 
frequently from the third decade onwards. Progressive 
changes within the intima and media of blood vessels 
results in luminal narrowing and complications such as 
stroke and myocardial ischaemia. Stroke may occur 
secondarily to large vessel disease, small vessel disease, 
or embolism from associated cardiac disease. 
Involvement of large vessels appears to affect the 
vertebrobasilar system preferentially, and therefore 
18,26ischaemia is most common in this territory.
MELAS, Mitochondrial Encephalomyelopathy, Lactic 
Acidosis and Stroke-like episodes, is a mitochondrial 
encephalopathy that is characterized by seizures, stroke-
like episodes, migraine-like headaches, nausea, 
 
familial syndrome of recurrent 
vomiting, lactic acidosis, ophthalmoplegia, ptosis, 
sensorineural hearing loss and dementia. It is caused by 
mutations in the mitochondrial DNA, which are 
transmitted maternally. Muscle biopsy usually reveals 
18,27abnormal mitochondria and ragged red fibres.
Arterial dissection could rarely be the consequence of an 
underlying heritable connective tissue disease resulting 
in ischaemic stroke. Defects in collagen synthesis can 
predispose individuals to spontaneous dissection of the 
extracranial carotid and vertebral arteries in 
Ehlers–Danlos syndrome type IV while in Marfan 
syndrome the common neurovascular complication is 
extension of an aortic dissection into the common carotid 
artery and there are isolated case reports of vertebral 
18dissection in osteogenesis imperfect.
Cardioembolic stroke
This category includes patients with arterial occlusions 
presumably due to an embolus arising in the heart. At least 
one cardiac source for an embolus must be identified for a 
possible or probable diagnosis of cardioembolic 
11stroke. This stroke can run in families with single-gene 
disorders including hereditary cardiac conduction 
defects, inherited cardiomyopathies and familial atrial 
myxomas. Cardiomyopathies may present as a primary 
cardiac disorder (e.g. hypertrophic obstructive 
cardiomyopathy) or be secondary to a neuromuscular 
disorder (e.g. Duchenne muscular dystrophy) or one of 
the inborn errors of metabolism (e.g. Menkes disease, an 
X-linked neurodegenerative disease). Idiopathic 
autosomal dominant mitral valve prolapse may confer a 
little risk of cardioembolic stroke but patients with forms 
of autosomal dominant or recessive dysrhythmias and 
28,29familial atrial myxoma may be at very high risk.
Familial aggregegation in polygenic multifactorial 
ischaemic stroke
Apart from rare monogenic disorders associated with 
stroke, ischemic stroke is a complex polygenic and 
multifactorial disorder caused by a combination of 
18genetic and environmental factors. Animal studies 
suggest that genetic factors may play a role in the 
susceptibil i ty to infarct ion during cerebral  
30ischemia. There is evidence in the literature, both from 
twin studies and from studies on the family history of 
stroke that genetic factors substantially contribute to 
31stroke susceptibility.  However, the influence of family 
history on stroke risk remains controversial, with some 
studies describing no impact of parental history on stroke 
32risk. The modulatory effect of genes on the extent and 
35
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pattern of end-organ damage resulting from conventional 
risk factors may be particularly important. For example, 
certain hypertensive individuals develop cerebral small 
vessel disease without any evidence of large vessel 
atherosclerosis, while in others the opposite occurs, or a 
combination of the two patterns may be present. The 
reasons for these different patterns are unknown but 
genetic factors may determine whether hypertensive 
individuals develop other manifestations of end-organ 
33damage, such as cardiac left ventricular hypertrophy.  
For each stroke subtypes, genetic factors may act either 
by predisposing to conventional risk factors such as 
hypertension, by modulating the effects of such 
conventional risk factors on the end organs, or by a direct 
independent effect on stroke risk. The well known 
conventional risk factors, such as hypertension, 
hyperlipidemia and diabetes are themselves believed to 
be under genetic control and run in families; twin and 
sibling studies have also shown that these intermediate 
31,34phenotypes for stroke are under strong genetic control.  
Epidemiological studies have used twin, affected sibling 
pair and family based approaches to investigate familial 
aggregation of stroke. 
31Using twin studies, Brass et al  found a stroke 
concordance rate of 17.7% in monozygotic twins as 
opposed to 3.6% in dizygotic twins, giving a relative risk 
of 4.3. However, it was not possible to calculate the 
heritability of stroke in this study as only a few twin pairs 
were studied. Later (after a decade), this cohort was 
reassessed and genetic influences was found to have little 
influence on the risk of stroke in the older population, in 
whom much of the variance was accounted for by 
environmental exposure. This is consistent with the role 
of genetic stroke risk factors being strongest in younger 
35
adults.
In another study, the heritability of common carotid artery 
intimal medial thickness was found to be 92%. Of 
interest, the role of genetic factors was not through usual 
risk factors used as covariates in the analysis. However, 
this study was performed in siblings rather than twins, 
making it not easy to account for the role of early shared 
36environmental effects and genetic influences.
Family based studies have examined the relationship 
between a family history of stroke amongst first-degree 
relatives and risk of stroke in probands. Whilst a positive 
family history is consistent with the role of genetic 
factors, alternative but not exclusive explanations, such 
as shared environmental influences, could be valid. With 
this in mind, the results of several large studies are 
consistent with a family history of stroke being an 
37important independent risk factor.  
In the original Framingham cohort it was reported that a 
parental history of stroke did not confer an increase in the 
risk of stroke but amongst the progeny cohort there was an 
association with parental stroke history. The presence of 
an atherothrombotic brain infarction in a sibling also 
38conferred a relative risk of 1.8.
The importance of parental history was also seen in a 
prospective follow-up of a Finnish population, in which a 
positive parental history of stroke led to a two fold 
increase in stroke in both men and women. The 
association between family and personal history of stroke 
35,39appeared to be stronger in younger stroke patients. This 
was also found in a cross-sectional study, in which 
younger stroke victims were more likely to have an 
offspring who had a fatal coronary or cerebrovascular 
event. A positive stroke history was recorded in 47% of 
patients, compared with 24% in the study by Graffagnino 
40et al.  However, the difference was no longer significant 
after controlling for conventional risk factors. 
Furthermore, as hypertension and diabetes are known to 
have a strong genetic component, clustering of these risk 
factors within families may partly account for the familial 
aggregation of stroke. This has been suggested by the 
study by Diaz and colleagues, in which it was found that 
siblings of patients with cerebral infarction or transient 
ischaemic attack were more likely to have multiple 
vascular risk factors than the siblings of spouse 
41controls. There have also been some notable negative 
studies. However, most studies suggest that a family 
history of stroke is an independent risk factor for stroke, 
and this is consistent with a genetic component operating 
outside the usual risk factors. In one study it was reported 
that a maternal history of stroke was associated with a 
42threefold increase in stroke in a cohort of men.  This is at 
odds with results from the Family Heart Study and the 
Framingham cohort, in which it was found that 
individuals with a paternal history of stroke were more 
likely to have a stroke than those with a maternal history, 
38which conferred a slightly lower risk.  Interestingly, in 
the Rancho Barnardo study, a family history of stroke in 
any first-degree relative at baseline was an independent 
predictor of stroke mortality in women but not in men, 
which suggests a sex-specific interaction for the genetic 
43risk of stroke.
Most cases of ischemic stroke represent a multifactorial, 
polygenic disorder or complex trait for which typical 
36
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model of inheritance cannot be established. Therefore, 
familial aggregation of this multifactorial stroke may be 
related to one or more of the following disorders of: (i) 
haemostasis, (ii) the renin–angiotensin system, (iii) nitric 
oxide production, (iv) homocysteine and (v) lipid 
metabolism.
Renin-Angiotensin System
The angiotensin-converting enzyme (ACE) gene 
(insertion or deletion polymorphism in intron 16) is one 
of the most commonly studied genetic variations in 
relation to atherosclerosis and vascular disease (coronary 
and cerebrovascular). ACE regulates vascular tone by 
converting angiotensin I to the vasoconstrictor 
angiotensin II inactivating the vasodilator bradykinin, 
hence contributing to the regulation of vascular tone, 
endothelial function, and smooth muscle cell 
proliferation. The insertion/deletion polymorphism in the 
ACE gene was significantly associated with lacunar 
44stroke with an increased risk for D-allele carriers.  A 
meta-analysis has evaluated the risk of stroke in 1918 
subjects versus 722 controls from seven studies. It was 
concluded that the ACE genotype conferred a small but 
modest effect, with an odds ratio of 1.31 (95% confidence 
interval 1.06–1.62), according to a dominant model of 
inheritance. A number of studies have reported an 
association that was strongest or exclusively with lacunar 
45,46stroke.
Thrombosis and Hemostasis
The role of platelet glycoprotein receptor polymorphism 
has also been studied extensively in patients with 
ischaemic stroke. Platelet glycoprotein receptors when 
activated, bind fibrinogen, von Willebrand factor, or 
collagen, and hence promote platelet aggregation and 
thrombosis. An increased risk of atherothrombotic stroke 
was found in A2-allele carriers of the integrin3 (ITGB3 or 
GPIIIa) P1(A1/A2) variant (rs5918) in different 
47,48studies.  
Factor XIII catalyzes the formation of covalent bounds 
between fibrin monomers, which stabilizes the fibrin clot, 
and is also involved in the cross-linking of 2 antiplasmin, 
fibronectin, and collagen. Studies also found an increased 
risk of atherothrombotic stroke associated with the 
Val/Val genotype of rs5985 in F13A1 (coagulation factor 
XIII, A1 polypeptide), but other studies found no 
association. A polymorphism in the factor XIII gene (Val 
34 Leu) has also been examined in ischaemic stroke after 





Inflammation is a key process in atherosclerosis and 
therefore stroke and coronary heart disease. Leukotrienes 
are potent proinflammatory molecules. One genetic 
variant in the leukotriene C4 synthase (LTC4S) gene was 
found to be associated with lacunar stroke in 2 different 
51populations, with an increased risk for A-allele carriers.  
Interleukin (IL)-6 inhibits the production of potent 
proinflammatory cytokines, such as tumor necrosis 
factor-and IL-1. Increased levels of IL-6 in the plasma and 
cerebrospinal fluid were shown to correlate with infarct 
size and functional outcome of patients with stroke. A 
genetic variant in the IL-6 gene was associated with 
lacunar stroke in 2 different populations, with an 
increased risk for CC-homozygotes. Raised fibrinogen 
levels may predispose to stroke both by accelerated 
51-53atherosclerosis and prothrombotic mechanisms. 
Lipid Metabolism
Individuals with increased plasma cholesterol, especially 
low-density lipoprotein, levels are at a higher risk of 
premature atherosclerosis. Thus, genes encoding proteins 
involved in plasma lipoprotein metabolism are interesting 
candidates when looking for genetic risk factors of 
54ischemic stroke.  The phenotype may arise not only from 
single gene disorders, as discussed above, but also from a 
number of genetic and environmental factors, including 
polymorphic variants of genes encoding the 
apolipoproteins, lipoprotein receptors and the key 
enzymes of plasma lipoprotein metabolism. 
Apolipoprotein E (ApoE), a glycoprotein mainly 
synthesized in hepatocytes, mediates the binding of lipid 
particles to specific lipoprotein receptors and there are 
three major alleles of ApoE gene encode E2, E3 and E4. 
Individuals who are homozygous for Apo E2 may 
d e v e l o p  s e v e r e  h y p e r l i p i d e m i a  ( t y p e  I I I  
dyslipoproteinemias), and complete absence of Apo E 
causes elevations of plasma levels of chylomychrons and 
VLDL remnants and early arthrosclerosis. The E4 variant 
has been associated with higher total serum cholesterol 
and LDL cholesterol levels, and has been postulated as an 
important risk factor in ischaemic stroke. An increased 
risk of atherothrombotic stroke was found for APOE 4 
55,56,57carriers in different studies.
Endothelial Function and Oxidative Stress
It is known that homocysteine levels tend to be higher in 
individuals homozygous for the MTHFR gene, due to a 
C-to-T transition at position 677 with increased risk of 
14atherothrombotic stroke in carriers of the TT genotype.  
37
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The activity of the L-arginine/nitric oxide synthase 
system is an important mediator of endothelial function. It 
has diverse effects, including the regulation of the tone, 
integrity, growth and thrombogenic properties of the 
58vessel wall.  Strong evidence from animal and human 
studies indicates that the activity of this system is under 
3 0 , 5 9genetic control.  Work in the stroke-prone 
Spontaneously Hypertensive Rat (SHR) has suggested 
that impaired endothelial function is an important 
predisposing factor leading to stroke. In addition, 
knockout mice deficient in endothelial nitric oxide 
synthase are highly sensitive to focal cerebral ischaemia 
60,61and have marked vessel wall abnormalities. The genes 
encoding nitric oxide synthase are potential candidate 
genes for stroke. In animal models, their inhibition 
reduces infarct size, which is also smaller in knockout 
mice. Both genes have been cloned and common 
polymorphisms described. 
Intracerebral hemorrhage (ICH)
As a complex disease, ICH 
aggregates in families but does not segregate in a 
mendelian fashion. Genes reported as associated with 
ICH are involved in the pathways of the vessel wall 
integrity (ACE, APOE, endoglin, TGF-â1), endothelial 
dysfunction (ACE), haemostasis (APOE, CD-14, Factors 
62,63VII and XIII) and inflammation markers (IL-6, TNF ).
 Woo D et al. reported that history of ICH in a first-degree




ICH is commonly classified according to the region of the 
brain in which it occurs—the thalamus, basal ganglia, 
brain stem, and cerebellum (“nonlobar”), or at the 
junction of the cortical gray matter and subcortical white 
matter (“lobar”). It occurs sporadically or as part of 
familial syndromes. 
 
ignificant independent risk factors for lobar ICH 
included the presence of an apolipoprotein E2 or E4 allele, 
frequent alcohol use, prior stroke, and first-degree relative 
with ICH. For nonlobar ICH significant independent risk 
factors included hypertension, prior stroke, and first-
64degree relative with ICH.  
Although ICH can result from rupture of vascular 
malformations and saccular aneurysms, the 
overwhelming majority of ICH in the elderly occurs as a 
manifestation of cerebral small vessel disease. Lobar 
ICH accounts for 25% to 35% of ICH depending on the 
population studied. Pathological studies demonstrate that 
the location of ICH in the elderly frequently signals 
different underlying small vessel diseases. For example, 
whereas chronic hypertension has long been recognized 
as a leading cause of ICH, the majority of ICH in lobar 
brain regions may be unrelated to hypertensive 
vasculopathy, arising instead from cerebral amyloid 
24,25,65angiopathy (CAA).  
Other risk factors are shared by both lobar and nonlobar 
ICH. For example, alcohol exposure appears to 
predispose to both lobar and nonlobar ICH. Data on 
familial aggregation point to a strong familial 
contribution to ICH, both lobar and nonlobar. The small 
vessel pathologies responsible for ICH can also cause 
other forms of brain injury. These are microbleeds, visible 
on MRI as dot-like susceptibility artifact and 
Leukoaraiosis is extremely common in the aging 
population and is strongly heritable. Studies demonstrate 
substantial heritability across multiple populations. 
Among 74 monozygotic and 71 dizygotic male American 
male twin pairs age 68 to 79 at time of MRI, heritability of 
25was 0.71 (95% CI 0.66 to 0.76).  
Microbleeds, but not ICH, commonly occur in 
CADASIL, the hallmark on neuroimaging is diffuse 
leukoaraiosis on MRI with particular involvement of 
bilateral anterior temporal lobes and external capsule, as 
24,25well as presence of microbleeds.
leukoaraiosis.
Subarachnoid hemorrhage (SAH)
Subarachnoid hemorrhage (SAH) comprises 1% to 7% of 
all strokes. Despite its relative rarity, it is a public health 
problem due to the relatively young age of onset and poor 
66outcome.
SAH, in 80%-90% of cases due to rupture of an 
intracranial aneurysm, occurs at all ages but strikes 
primarily in middle age, frequently with devastating 
consequences: around 40% of patients admitted to 
hospital die within 1 month and more than one third of 
67survivors have severe disability.  Several studies have 
indicated that smoking, hypertension, and alcohol misuse 
are important risk factors for subarachnoid haemorrhage 
due to aneurysms. Genetic factors may also have a role as 
close relatives harbour intracerebral aneurysms more 
frequently than the background population. Furthermore, 
intracranial aneurysms have been associated with 
numerous heritable connective tissue disorders, which 
account for at least 5% of cases. Of these disorders, the 
most important are Ehlers-Danlos syndrome Type IV, 
Marfan's syndrome, neurofibromatosis Type 1, and 
autosomal dominant polycystic kidney disease; the 
association with intracranial aneurysms, however, has 
been firmly established only for polycystic kidney 
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account for 7 to 20% of patients with aneurysmal 
subarachnoid hemorrhage and are generally not 
associated with any of the known heritable connective 
68tissue disorders.
Familial studies indicate that first degree relatives 
(parents, full siblings, and children) are at increased risk 
of subarachnoid haemorrhage. In most studies, 
information on pedigrees and identification of cases 
among relatives are based on self reported or proxy 
reported data, which can be subject to selection and recall 
biases making quantitative estimates inaccurate.
Population based registries are less likely to be subject to 
69recall bias.
Although familial preponderance suggests a genetic 
influence, most instances of SAH can be attributed to 
lifestyle exposures. Hence, identification of modifiable 
risk factors for SAH is pivotal to reducing its incidence, 
which appears to have remained relatively stable in many 
66countries over recent decades.
First degree relatives of patients who had a subarachnoid 
haemorrhage are at an estimated threefold to fivefold 
increased risk of subarachnoid haemorrhage compared 
with the general population. 
 A family history of SAH has been linked withan increased 
risk for SAH of about 4 fold; for this reason, screening of 
 first-degree relatives of patients with SAH is 
 recommended. Evidence of a gene-environment
interaction with smoking, another risk factor for SAH, 
 70alsomay exist for aneurysmal SAH.
Familial cases of intracranial aneurysm have been 
reported to occur, with a slight preponderance in women, 
at a younger age, and with similar severity and case 
fatality as non-familial cases. The pathogenesis of 
familial intracranial aneurysms is not fully explained; a 
deficiency of type III collagen has been reported in 
70sporadic, but not in familial, cases.  
Some families show a frequency of intracranial 
aneurysms compatible with an autosomal dominant mode 
of inheritance. A genetic basis is also suggested by the 
younger average age of familial cases with a ruptured 
intracranial aneurysm, occurrence at the same site or a 
mirror site in sibling pairs, occurrence in identical twins, 
and the association of intracranial aneurysms with 
71genetically transmitted disorders.
In a case-control study of 149 patients with subarachnoid 
haemorrhage, cases were 1.8 times more likely than 
 
 
controls to report having first degree relatives with 
subarachnoid haemorrhage. In another study, 11 first 
degree relatives of 76 patients with subarachnoid 
haemorrhage had an aneurysmal subarachnoid 
haemorrhage, which corresponded to a relative risk of 4.1 
compared with the background population.  De 
Braekeleer et al traced 533 cases of subarachnoid 
haemorrhage and unruptured intracranial aneurysms 
through hospital registries, and matched controls were 
identified through a population register in an isolated 
population with a high degree of inbreeding. Cases were 
4.7 times more likely to have affected first degree 
72,73relatives than were controls. 
Smoking, hypertension, and excessive alcohol intake 
have statistically significant and consistent associations 
with an increased risk of SAH in case-control and 
longitudinal studies. Because of the increase in the 
number of studies in this analysis, the estimates of 
association obtained are more precise. Studies found that 
the risk of SAH in former smokers is almost twice that of 
67never smokers.  
CONCLUSION
Most studies suggest that a family history of stroke is an 
independent risk factor for stroke and a positive family 
history of vascular disease is an independent risk factor 
for both hemorrhagic and ischemic strokes, especially in 
the young patient without usual cardiovascular risk 
factors. Although family history of stroke is one of 
important stroke risk factor, recall bias is among 
important biases in family history studies.
The importance of the accurate classification of stroke 
 type and subtype in studies needs to be appreciated, as 
ischemic and hemorrhagic strokes are not under the same 
genetic influence.Most studies report familial 
aggregation of all strokes but stroke types and subtypes 
are not expected to be evenly heritable, and case merge is 
so prone to influence the findings. 
Most familial stroke studies report strong association of 
stroke between siblings compared with the rather weak 
association of stroke between spouses suggesting that 
genetic factors might be stronger predictors of stroke than 
environmental factors. However, further studies of the 
human genome are needed in order to identify the specific 
genes that play roles in the pathogenesis of different types 
and subtypes of stroke.
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